lomustine   Click here for help

GtoPdb Ligand ID: 7214

Synonyms: CCNU | CeeNU®
Approved drug
lomustine is an approved drug (FDA (1976))
Compound class: Synthetic organic
Comment: Lomustine is an antineoplastic DNA alkylating agent.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: lomustine

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 65.26
Molecular weight 233.09
XLogP 2.31
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES ClCCN(C(=NC1CCCCC1)O)N=O
Isomeric SMILES ClCCN(C(=NC1CCCCC1)O)N=O
InChI InChI=1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14)
InChI Key GQYIWUVLTXOXAJ-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Lomustine is used to treat brain and lung tumors, metastatic melanoma and Hodgkin's disease. This drug is generally used clinically in combination with radiotherapy and/or surgery.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
As a DNA alkylating (cross-linking) agent, lomustine treatment irreversibly interferes with DNA replication, RNA transcription and general disruption of nucleic acid function. This action causes cell death. Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.
External links Click here for help